SCHEMBL10093232

SCHEMBL10093232

CCNC(=O)c1ccc(N)c(F)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.65
HDAC6 Q9UBN7 2/20 0.65
ALOX15 P16050 1/20 0.50
CTSL P07711 1/20 0.49
CTSS P25774 1/20 0.49
CTSK P43235 1/20 0.49
PDK2 Q15119 2/20 0.44
KDM4E B2RXH2 2/20 0.43
HDAC3 O15379 1/20 0.42
ALDH1A1 P00352 2/20 0.42
ANPEP P15144 1/20 0.41
BRD4 O60885 1/20 0.41
LMNA P02545 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
GFER P55789 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL603156 0.87 ALOX15 (0.53) HDAC1HDAC6ALOX15PDK2KDM4E
SCHEMBL532190 0.84 CES2 (0.53) HDAC1HDAC6PDK2HDAC3ALDH1A1
Hydrochloric Acid SCHEMBL27687311 0.83 ALOX15 (0.56) HDAC1HDAC6ALOX15PDK2KDM4E
Hydrochloric Acid SCHEMBL2952907 0.83 ALOX15 (0.56) HDAC1HDAC6ALOX15PDK2KDM4E
SCHEMBL18642563 0.82 HDAC1 (0.73) HDAC1HDAC6CTSLCTSSCTSK
SCHEMBL15631040 0.82 HDAC1 (0.63) HDAC1HDAC6CTSLCTSSCTSK
SCHEMBL15630979 0.82 HDAC1 (0.63) HDAC1HDAC6CTSLCTSSCTSK
SCHEMBL15610485 0.82 HDAC1 (0.63) HDAC1HDAC6CTSLCTSSCTSK
SCHEMBL3112864 0.81 ALOX15 (0.51) HDAC1HDAC6ALOX15PDK2KDM4E
SCHEMBL23417941 0.81 ESRRG (0.57) HDAC1HDAC6ALOX15PDK2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010542-B1 4,5-DIHYDRO-[1,2,4]TRIAZOLO[4,3-F]PTERIDINES AS PLK1 PROTEIN KINASE INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS VERTEX PHARMA (US) 2012-01-25 EP disclosed
WO-2011038185-A2 METHODS FOR PREPARING PYRIMIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-03-31 WO disclosed
WO-2007120752-A2 4, 5-DIHYDRO- [1, 2, 4] TRIAZOLO [4, 3-F] PTERIDINES AS PROTEIN KINASE PLK1 INHIBITORS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-10-25 WO disclosed